RE:RE:$29 million vs $525 millionYou created a profile today to post this info? This is still a speculative stock and with it comes a compelling risk reward opportunity. Hemostemix's bio tech is not limited to CLI. It covers the full spectrum of ailments--heart, lung, liver etc. The disconnect is very real. I intend to either make a fortune on this stock in 2021 or I hold longer to make a fortune. One way or the other. Like everyone, my preference is always sooner rather than later.